Μιρταζαπίνη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Μιρταζαπίνη" in Greek language version.

refsWebsite

Global rank Greek rank

74nih.gov

4^th place

52doi.org

2^nd place

3^rd place

13archive.org

6^th place

5^th place

5web.archive.org

1^st place

3drugs.com

399^th place

130^th place

3books.google.com

3^rd place

6^th place

3worldcat.org

5^th place

8^th place

2clincalc.com

3,912^th place

594^th place

2semanticscholar.org

11^th place

576^th place

1tga.gov.au

3,984^th place

2,133^rd place

1medicines.org.uk

3,823^rd place

2,141^st place

1aafp.org

1,916^th place

1,112^th place

1psychiatrictimes.com

9,815^th place

7,251^st place

1oxfordjournals.org

1,389^th place

724^th place

1medscape.com

719^th place

579^th place

1amh.net.au

low place

1rxlist.com

7,927^th place

3,123^rd place

1cambridge.org

305^th place

354^th place

1drugbank.ca

4,294^th place

4,484^th place

1medicinescomplete.com

low place

5,144^th place

1healthlinks.net.au

low place

1vetinfo.com

low place

1veterinarypartner.com

low place

1europa.eu

68^th place

24^th place

aafp.org

«FPIN's clinical inquiries: Antidepressants for the treatment of insomnia in patients with depression». American Family Physician 84 (9): 1–2. November 2011. PMID 22164891. http://www.aafp.org/afp/2011/1101/od1.pdf.

amh.net.au

«Australian Medicines Handbook». Australian Medicines Handbook Pty Ltd. 2013.

archive.org

«3». Manual of Clinical Psychopharmacology (7th έκδοση). Arlington, VA: American Psychiatric Publishing. 2010. ISBN 978-1-58562-377-8.
«Mirtazapine in major depression with comorbid generalized anxiety disorder». The Journal of Clinical Psychiatry 60 (7): 446–8. July 1999. doi:10.4088/JCP.v60n0705. PMID 10453798. https://archive.org/details/sim_journal-of-clinical-psychiatry_1999-07_60_7/page/446.
British National Formulary (BNF) (65th έκδοση). Pharmaceutical Press. 2013. σελ. 1120. ISBN 978-0857110848.
«Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial». The Journal of Clinical Psychiatry 72 (7): 885–91. July 2011. doi:10.4088/JCP.09m05853blu. PMID 21294998. https://archive.org/details/sim_journal-of-clinical-psychiatry_2011-07_72_7/page/885.
«Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression». Journal of Affective Disorders 51 (3): 267–85. December 1998. doi:10.1016/S0165-0327(98)00224-9. PMID 10333982. https://archive.org/details/sim_journal-of-affective-disorders_1998-12_51_3/page/267.
«Switch to mania upon discontinuation of antidepressants in patients with mood disorders: a review of the literature». Canadian Journal of Psychiatry 48 (4): 258–64. May 2003. doi:10.1177/070674370304800410. PMID 12776393. https://archive.org/details/sim_canadian-journal-of-psychiatry_2003-05_48_4/page/258.
Maudsley Prescribing Guidelines in Psychiatry (11th έκδοση). West Sussex: Wiley-Blackwell. 2012. ISBN 978-0-47-097948-8.
Houlihan, David J. (March 2004). «Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine». The Annals of Pharmacotherapy 38 (3): 411–413. doi:10.1345/aph.1D344. ISSN 1060-0280. PMID 14970364. https://archive.org/details/sim_annals-of-pharmacotherapy_2004-03_38_3/page/411.
«A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status». Hum Psychopharmacol 21 (2): 117–25. 2006. doi:10.1002/hup.750. PMID 16342227. https://archive.org/details/sim_human-psychopharmacology_2006-03_21_2/page/117.
«Pharmacology of antidepressants». Mayo Clin. Proc. 76 (5): 511–27. 2001. doi:10.4065/76.5.511. PMID 11357798. https://archive.org/details/sim_mayo-clinic-proceedings_2001-05_76_5/page/511.
«Tricyclic antidepressant pharmacology and therapeutic drug interactions updated». Br. J. Pharmacol. 151 (6): 737–48. 2007. doi:10.1038/sj.bjp.0707253. PMID 17471183. PMC 2014120. https://archive.org/details/sim_british-journal-of-pharmacology_2007-07_151_6/page/737.
«Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats: a pharmacological characterization». Psychopharmacology 203 (2): 329–41. April 2009. doi:10.1007/s00213-008-1259-8. PMID 18709360. https://archive.org/details/sim_psychopharmacology_2009-04_203_2/page/329.
«Mirtazapine for treatment of nausea induced by selective serotonin reuptake inhibitors». Canadian Journal of Psychiatry 49 (10): 707. October 2004. doi:10.1177/070674370404901014. PMID 15560319. https://archive.org/details/sim_canadian-journal-of-psychiatry_2004-10_49_10/page/707.

books.google.com

Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. σελίδες 696–. ISBN 978-3-88763-075-1.
Laurence Brunton· Bruce A. Chabner (14 Ιανουαρίου 2011). Goodman and Gilman's The Pharmacological Basis of Therapeutics, Twelfth Edition. McGraw Hill Professional. σελ. 410. ISBN 978-0-07-176939-6.
Alan F. Schatzberg· Charles B. Nemeroff (10 Μαΐου 2017). The American Psychiatric Association Publishing Textbook of Psychopharmacology. American Psychiatric Pub. σελίδες 322–. ISBN 978-1-61537-122-8.

cambridge.org

stahlonline.cambridge.org

Stahl's Essential Psychopharmacology Online: Print and Online. Cambridge, UK: Cambridge University Press. 2008. ISBN 978-0-521-74609-0. Αρχειοθετήθηκε από το πρωτότυπο στις 19 Ιουνίου 2020. Ανακτήθηκε στις 28 Σεπτεμβρίου 2020.

clincalc.com

«The Top 300 of 2020». ClinCalc. Ανακτήθηκε στις 11 Απριλίου 2020.
«Mirtazapine - Drug Usage Statistics». ClinCalc. Ανακτήθηκε στις 11 Απριλίου 2020.

doi.org

dx.doi.org

«Clinical pharmacokinetics of mirtazapine». Clinical Pharmacokinetics 38 (6): 461–74. June 2000. doi:10.2165/00003088-200038060-00001. PMID 10885584.
«A review of the pharmacological and clinical profile of mirtazapine». CNS Drug Rev 7 (3): 249–64. 2001. doi:10.1111/j.1527-3458.2001.tb00198.x. PMID 11607047.
«Mirtazapine versus other antidepressive agents for depression». The Cochrane Database of Systematic Reviews (12): CD006528. December 2011. doi:10.1002/14651858.CD006528.pub2. PMID 22161405.
«Tolerability and safety aspects of mirtazapine». Hum Psychopharmacol 17 Suppl 1: S37–41. 2002. doi:10.1002/hup.388. PMID 12404669.
«Review of the use of mirtazapine in the treatment of depression». Expert Opinion on Pharmacotherapy 12 (10): 1623–32. July 2011. doi:10.1517/14656566.2011.585459. PMID 21644844.
«Onset of action of antidepressants: results of different analyses». Human Psychopharmacology 17 Suppl 1: S27–32. June 2002. doi:10.1002/hup.386. PMID 12404667.
«Mirtazapine in major depression with comorbid generalized anxiety disorder». The Journal of Clinical Psychiatry 60 (7): 446–8. July 1999. doi:10.4088/JCP.v60n0705. PMID 10453798. https://archive.org/details/sim_journal-of-clinical-psychiatry_1999-07_60_7/page/446.
«Mirtazapine: a review of its use in major depression and other psychiatric disorders». CNS Drugs 23 (5): 427–52. 2009. doi:10.2165/00023210-200923050-00006. PMID 19453203.
«Appetite stimulants in cystic fibrosis: a systematic review». Journal of Human Nutrition and Dietetics 20 (6): 526–37. December 2007. doi:10.1111/j.1365-277X.2007.00824.x. PMID 18001374. https://semanticscholar.org/paper/23bee19e5db3f46e66e00efa318ea014b1516dda.
«Management of symptoms associated with advanced cancer: olanzapine and mirtazapine. A World Health Organization project». Expert Review of Anticancer Therapy 2 (4): 365–76. August 2002. doi:10.1586/14737140.2.4.365. PMID 12647979.
«Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature». The Journal of ECT 27 (2): 165–7. June 2011. doi:10.1097/YCT.0b013e3181e63346. PMID 21602639.
«Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT₃ antagonists with good antinausea effects». European Journal of Cancer Care 16 (4): 351–4. July 2007. doi:10.1111/j.1365-2354.2006.00760.x. PMID 17587360.
«Itch: scratching more than the surface». QJM 96 (1): 7–26. January 2003. doi:10.1093/qjmed/hcg002. PMID 12509645. http://qjmed.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=12509645.
«Itch in systemic disease: therapeutic options». Dermatologic Therapy 18 (4): 323–7. 2005. doi:10.1111/j.1529-8019.2005.00036.x. PMID 16297004.
«Therapy of primary headaches: the role of antidepressants». Neurological Sciences 25 Suppl 3: S171–5. October 2004. doi:10.1007/s10072-004-0280-x. PMID 15549531.
«Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial». The Journal of Clinical Psychiatry 72 (7): 885–91. July 2011. doi:10.4088/JCP.09m05853blu. PMID 21294998. https://archive.org/details/sim_journal-of-clinical-psychiatry_2011-07_72_7/page/885.
«The effect of antidepressants on lipid homeostasis: a cardiac safety concern?». Expert Opinion on Drug Safety 5 (4): 523–37. July 2006. doi:10.1517/14740338.5.4.523. PMID 16774491.
«Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression». Journal of Affective Disorders 51 (3): 267–85. December 1998. doi:10.1016/S0165-0327(98)00224-9. PMID 10333982. https://archive.org/details/sim_journal-of-affective-disorders_1998-12_51_3/page/267.
«Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review». European Archives of Psychiatry and Clinical Neuroscience 256 (8): 476–96. December 2006. doi:10.1007/s00406-006-0689-8. PMID 17143567.
«Switch to mania upon discontinuation of antidepressants in patients with mood disorders: a review of the literature». Canadian Journal of Psychiatry 48 (4): 258–64. May 2003. doi:10.1177/070674370304800410. PMID 12776393. https://archive.org/details/sim_canadian-journal-of-psychiatry_2003-05_48_4/page/258.
«Suicidal antidepressant overdoses: a comparative analysis by antidepressant type». Journal of Medical Toxicology 4 (4): 238–50. December 2008. doi:10.1007/bf03161207. PMID 19031375.
«California rocket fuel: And what about being a first line treatment?». European Psychiatry 33: S551. March 2016. doi:10.1016/j.eurpsy.2016.01.2033.
Saguin, Emeric; Keou, S.; Ratnam, C.; Mennessier, C.; Delacour, H.; Lahutte, B. (May 2018). «Severe rhabdomyolysis induced by quetiapine and mirtazapine in a French military soldier». Journal of the Royal Army Medical Corps 164 (2): 127–129. doi:10.1136/jramc-2018-000939. ISSN 0035-8665. PMID 29632134.
Houlihan, David J. (March 2004). «Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine». The Annals of Pharmacotherapy 38 (3): 411–413. doi:10.1345/aph.1D344. ISSN 1060-0280. PMID 14970364. https://archive.org/details/sim_annals-of-pharmacotherapy_2004-03_38_3/page/411.
«A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action». Biological Psychiatry 59 (11): 1046–51. June 2006. doi:10.1016/j.biopsych.2005.11.016. PMID 16460699.
«A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status». Hum Psychopharmacol 21 (2): 117–25. 2006. doi:10.1002/hup.750. PMID 16342227. https://archive.org/details/sim_human-psychopharmacology_2006-03_21_2/page/117.
«Pharmacology of antidepressants». J Clin Psychopharmacol 17 Suppl 1: 2S–18S. 1997. doi:10.1097/00004714-199704001-00002. PMID 9090573.
«Synthesis and biodistribution of [11C]R107474, a new radiolabeled alpha2-adrenoceptor antagonist». Bioorg. Med. Chem. 14 (13): 4526–34. 2006. doi:10.1016/j.bmc.2006.02.029. PMID 16517171.
«Pharmacology of antidepressants». Mayo Clin. Proc. 76 (5): 511–27. 2001. doi:10.4065/76.5.511. PMID 11357798. https://archive.org/details/sim_mayo-clinic-proceedings_2001-05_76_5/page/511.
«Tricyclic antidepressant pharmacology and therapeutic drug interactions updated». Br. J. Pharmacol. 151 (6): 737–48. 2007. doi:10.1038/sj.bjp.0707253. PMID 17471183. PMC 2014120. https://archive.org/details/sim_british-journal-of-pharmacology_2007-07_151_6/page/737.
«Histamine H₁ receptor occupancy by the new-generation antidepressants fluvoxamine and mirtazapine: a positron emission tomography study in healthy volunteers». Psychopharmacology 230 (2): 227–34. 2013. doi:10.1007/s00213-013-3146-1. PMID 23728612.
«The atypical antidepressant mianserin exhibits agonist activity at κ-opioid receptors». British Journal of Pharmacology 167 (6): 1329–41. November 2012. doi:10.1111/j.1476-5381.2012.02078.x. PMID 22708686.
«Serotonin 5-HT_2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies». Thérapie 60 (5): 441–60. 2005. doi:10.2515/therapie:2005065. PMID 16433010.
«Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats: a pharmacological characterization». Psychopharmacology 203 (2): 329–41. April 2009. doi:10.1007/s00213-008-1259-8. PMID 18709360. https://archive.org/details/sim_psychopharmacology_2009-04_203_2/page/329.
«Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of α2-adrenergic and serotonin2C receptors: a comparison with citalopram». Eur. J. Neurosci. 12 (3): 1079–95. March 2000. doi:10.1046/j.1460-9568.2000.00982.x. PMID 10762339.
«Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram». The European Journal of Neuroscience 12 (3): 1079–95. March 2000. doi:10.1046/j.1460-9568.2000.00982.x. PMID 10762339.
«SB 206553, a putative 5-HT_2C inverse agonist, attenuates methamphetamine-seeking in rats». BMC Neuroscience 13 (1): 65. June 2012. doi:10.1186/1471-2202-13-65. PMID 22697313.
«Mirtazapine to reduce methamphetamine use: a randomized controlled trial». Archives of General Psychiatry 68 (11): 1168–75. November 2011. doi:10.1001/archgenpsychiatry.2011.124. PMID 22065532.
«Mirtazapine treatment after conditioning with methamphetamine alters subsequent expression of place preference». Drug and Alcohol Dependence 99 (1–3): 231–9. January 2009. doi:10.1016/j.drugalcdep.2008.08.005. PMID 18945553.
«Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions». Annals of Clinical Psychiatry 20 (3): 145–55. 2008. doi:10.1080/10401230802177656. PMID 18633741.
«Treatments for methamphetamine abuse: a literature review for the clinician». Journal of Pharmacy Practice 24 (6): 541–50. December 2011. doi:10.1177/0897190011426557. PMID 22095579.
«Pharmacotherapy of amphetamine-type stimulant dependence: an update». Drug and Alcohol Review 32 (5): 449–60. September 2013. doi:10.1111/dar.12048. PMID 23617468.
«Mirtazapine may be useful in treating nausea and insomnia of cancer chemotherapy». Supportive Care in Cancer 9 (6): 469–70. September 2001. doi:10.1007/s005200000215. PMID 11585276.
«Mirtazapine for treatment of nausea induced by selective serotonin reuptake inhibitors». Canadian Journal of Psychiatry 49 (10): 707. October 2004. doi:10.1177/070674370404901014. PMID 15560319. https://archive.org/details/sim_canadian-journal-of-psychiatry_2004-10_49_10/page/707.
«Mirtazapine overdose is unlikely to cause major toxicity». Clin Toxicol 52 (1): 20–4. 2014. doi:10.3109/15563650.2013.859264. PMID 24228948.
«[Serotonin syndrome after administration of mirtazapine in a critical care unit]» (στα Spanish). Rev Esp Anestesiol Reanim 56 (8): 515–6. 2009. doi:10.1016/s0034-9356(09)70444-x. PMID 19994622.
«Sertraline-induced serotonin syndrome followed by mirtazapine reaction». Prog. Neuropsychopharmacol. Biol. Psychiatry 34 (6): 1128–9. 2010. doi:10.1016/j.pnpbp.2010.04.015. PMID 20430060.
«A venlafaxine and mirtazapine-induced serotonin syndrome confirmed by de- and re-challenge». Int J Clin Pharm 34 (5): 686–8. 2012. doi:10.1007/s11096-012-9666-7. PMID 22752315.
«Mirtazapine: clinical advantages in the treatment of depression». Journal of Clinical Psychopharmacology 17 Suppl 1: 34S–39S. April 1997. doi:10.1097/00004714-199704001-00005. PMID 9090576.
Anttila, SA; Leinonen, EV (2001). «A review of the pharmacological and clinical profile of mirtazapine.». CNS Drug Reviews 7 (3): 249–64. doi:10.1111/j.1527-3458.2001.tb00198.x. PMID 11607047.
Kelder, J; Funke, C; De Boer, T; Delbressine, L; Leysen, D; Nickolson, V (April 1997). «A comparison of the physicochemical and biological properties of mirtazapine and mianserin.». The Journal of Pharmacy and Pharmacology 49 (4): 403–11. doi:10.1111/j.2042-7158.1997.tb06814.x. PMID 9232538.
Agnew, W; Korman, R (September 2014). «Pharmacological appetite stimulation: rational choices in the inappetent cat.». Journal of Feline Medicine and Surgery 16 (9): 749–56. doi:10.1177/1098612X14545273. PMID 25146662.

drugbank.ca

«Mirtazapine». Drugbank. Ανακτήθηκε στις 16 Ιανουαρίου 2020.

drugs.com

«Mirtazapine Use During Pregnancy». Drugs.com. 23 Σεπτεμβρίου 2019. Ανακτήθηκε στις 4 Μαρτίου 2020.
«Mirtazapine - Drugs.com».
«Mirtazapine Monograph for Professionals». Drugs.com. American Society of Health-System Pharmacists. Ανακτήθηκε στις 20 Νοεμβρίου 2018.

europa.eu

ema.europa.eu

«Mirataz EPAR». European Medicines Agency. 11 Οκτωβρίου 2019. Ανακτήθηκε στις 12 Ιουλίου 2020. Text was copied from this source, which is © European Medicines Agency, 2020. Reproduction is authorised provided the source is acknowledged.

healthlinks.net.au

secure.healthlinks.net.au

«Mirtazapine label – Australia». GuildLink, a wholly owned subsidiary company of the Pharmacy Guild of Australia. 27 Μαΐου 2016. Αρχειοθετήθηκε από το πρωτότυπο στις 21 Νοεμβρίου 2018. Ανακτήθηκε στις 28 Σεπτεμβρίου 2020.

medicines.org.uk

«Mirtazapine 30 mg Tablets – Summary of Product Characteristics». electronic Medicines Compendium. Sandoz Limited. 20 Μαρτίου 2013. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 31 Ιουλίου 2017. Ανακτήθηκε στις 24 Οκτωβρίου 2013.

medicinescomplete.com

Brayfield, A, επιμ. (30 Ιανουαρίου 2013). Mirtazapine. The Royal Pharmaceutical Society of Great Britain. Ανακτήθηκε στις 3 Νοεμβρίου 2013.

medscape.com

reference.medscape.com

«mirtazapine (Rx) – Remeron, Remeron SolTab». Medscape. WebMD. Ανακτήθηκε στις 24 Οκτωβρίου 2013.

nih.gov

ncbi.nlm.nih.gov

«Clinical pharmacokinetics of mirtazapine». Clinical Pharmacokinetics 38 (6): 461–74. June 2000. doi:10.2165/00003088-200038060-00001. PMID 10885584.
«A review of the pharmacological and clinical profile of mirtazapine». CNS Drug Rev 7 (3): 249–64. 2001. doi:10.1111/j.1527-3458.2001.tb00198.x. PMID 11607047.
«Mirtazapine versus other antidepressive agents for depression». The Cochrane Database of Systematic Reviews (12): CD006528. December 2011. doi:10.1002/14651858.CD006528.pub2. PMID 22161405.
«Tolerability and safety aspects of mirtazapine». Hum Psychopharmacol 17 Suppl 1: S37–41. 2002. doi:10.1002/hup.388. PMID 12404669.
«Mirtazapine: clinical overview». The Journal of Clinical Psychiatry 60 Suppl 17: 9–13; discussion 46–8. 1999. PMID 10446735.
«Review of the use of mirtazapine in the treatment of depression». Expert Opinion on Pharmacotherapy 12 (10): 1623–32. July 2011. doi:10.1517/14656566.2011.585459. PMID 21644844.
«Onset of action of antidepressants: results of different analyses». Human Psychopharmacology 17 Suppl 1: S27–32. June 2002. doi:10.1002/hup.386. PMID 12404667.
Pharmacological Interventions: 10.14. Clinical Practice Recommendations. National Collaborating Centre for Mental Health/British Psychological Society. 2010.
Pharmacological Interventions: Third-Generation Antidepressants: 10.8.3. Mirtazapine. National Collaborating Centre for Mental Health/British Psychological Society. 2010.
«Mirtazapine in major depression with comorbid generalized anxiety disorder». The Journal of Clinical Psychiatry 60 (7): 446–8. July 1999. doi:10.4088/JCP.v60n0705. PMID 10453798. https://archive.org/details/sim_journal-of-clinical-psychiatry_1999-07_60_7/page/446.
«Mirtazapine: a review of its use in major depression and other psychiatric disorders». CNS Drugs 23 (5): 427–52. 2009. doi:10.2165/00023210-200923050-00006. PMID 19453203.
«[Mirtazapine—an antidepressant]» (στα Polish). Psychiatria Polska 36 (6 Suppl): 125–30. 2002. PMID 12647431.
«Appetite stimulants in cystic fibrosis: a systematic review». Journal of Human Nutrition and Dietetics 20 (6): 526–37. December 2007. doi:10.1111/j.1365-277X.2007.00824.x. PMID 18001374. https://semanticscholar.org/paper/23bee19e5db3f46e66e00efa318ea014b1516dda.
«Management of symptoms associated with advanced cancer: olanzapine and mirtazapine. A World Health Organization project». Expert Review of Anticancer Therapy 2 (4): 365–76. August 2002. doi:10.1586/14737140.2.4.365. PMID 12647979.
«FPIN's clinical inquiries: Antidepressants for the treatment of insomnia in patients with depression». American Family Physician 84 (9): 1–2. November 2011. PMID 22164891. http://www.aafp.org/afp/2011/1101/od1.pdf.
«Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature». The Journal of ECT 27 (2): 165–7. June 2011. doi:10.1097/YCT.0b013e3181e63346. PMID 21602639.
«Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT₃ antagonists with good antinausea effects». European Journal of Cancer Care 16 (4): 351–4. July 2007. doi:10.1111/j.1365-2354.2006.00760.x. PMID 17587360.
«Itch: scratching more than the surface». QJM 96 (1): 7–26. January 2003. doi:10.1093/qjmed/hcg002. PMID 12509645. http://qjmed.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=12509645.
«Itch in systemic disease: therapeutic options». Dermatologic Therapy 18 (4): 323–7. 2005. doi:10.1111/j.1529-8019.2005.00036.x. PMID 16297004.
«Therapy of primary headaches: the role of antidepressants». Neurological Sciences 25 Suppl 3: S171–5. October 2004. doi:10.1007/s10072-004-0280-x. PMID 15549531.
«Effects of mirtazapine in patients with chronic tension-type headache. Literature review» (στα Hungarian). Neuropsychopharmacologia Hungarica 8 (2): 67–72. June 2006. PMID 17073214.
«Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial». The Journal of Clinical Psychiatry 72 (7): 885–91. July 2011. doi:10.4088/JCP.09m05853blu. PMID 21294998. https://archive.org/details/sim_journal-of-clinical-psychiatry_2011-07_72_7/page/885.
«The effect of antidepressants on lipid homeostasis: a cardiac safety concern?». Expert Opinion on Drug Safety 5 (4): 523–37. July 2006. doi:10.1517/14740338.5.4.523. PMID 16774491.
«Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression». Journal of Affective Disorders 51 (3): 267–85. December 1998. doi:10.1016/S0165-0327(98)00224-9. PMID 10333982. https://archive.org/details/sim_journal-of-affective-disorders_1998-12_51_3/page/267.
«Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review». European Archives of Psychiatry and Clinical Neuroscience 256 (8): 476–96. December 2006. doi:10.1007/s00406-006-0689-8. PMID 17143567.
«Pharmacology of rapid-onset antidepressant treatment strategies». The Journal of Clinical Psychiatry 62 Suppl 15: 12–7. 2001. PMID 11444761.
«[Withdrawal symptoms of antidepressants]» (στα nl). Nederlands Tijdschrift voor Geneeskunde 149 (13): 698–701. March 2005. PMID 15819135.
«Switch to mania upon discontinuation of antidepressants in patients with mood disorders: a review of the literature». Canadian Journal of Psychiatry 48 (4): 258–64. May 2003. doi:10.1177/070674370304800410. PMID 12776393. https://archive.org/details/sim_canadian-journal-of-psychiatry_2003-05_48_4/page/258.
«Suicidal antidepressant overdoses: a comparative analysis by antidepressant type». Journal of Medical Toxicology 4 (4): 238–50. December 2008. doi:10.1007/bf03161207. PMID 19031375.
Wu, Chi-Shun; Tong, Show-Hwa; Ong, Cheung-Ter; Sung, Sheng-Feng (December 2015). «Serotonin Syndrome Induced by Combined Use of Mirtazapine and Olanzapine Complicated with Rhabdomyolysis, Acute Renal Failure, and Acute Pulmonary Edema-A Case Report». Acta Neurologica Taiwanica 24 (4): 117–121. ISSN 1028-768X. PMID 27333965.
Saguin, Emeric; Keou, S.; Ratnam, C.; Mennessier, C.; Delacour, H.; Lahutte, B. (May 2018). «Severe rhabdomyolysis induced by quetiapine and mirtazapine in a French military soldier». Journal of the Royal Army Medical Corps 164 (2): 127–129. doi:10.1136/jramc-2018-000939. ISSN 0035-8665. PMID 29632134.
Houlihan, David J. (March 2004). «Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine». The Annals of Pharmacotherapy 38 (3): 411–413. doi:10.1345/aph.1D344. ISSN 1060-0280. PMID 14970364. https://archive.org/details/sim_annals-of-pharmacotherapy_2004-03_38_3/page/411.
«A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action». Biological Psychiatry 59 (11): 1046–51. June 2006. doi:10.1016/j.biopsych.2005.11.016. PMID 16460699.
«A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status». Hum Psychopharmacol 21 (2): 117–25. 2006. doi:10.1002/hup.750. PMID 16342227. https://archive.org/details/sim_human-psychopharmacology_2006-03_21_2/page/117.
«Overview of serotonin syndrome». Ann Clin Psychiatry 24 (4): 310–8. 2012. PMID 23145389.
«Pharmacology of antidepressants». J Clin Psychopharmacol 17 Suppl 1: 2S–18S. 1997. doi:10.1097/00004714-199704001-00002. PMID 9090573.
«Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers». Neuro Endocrinology Letters 31 (5): 645–56. 2010. PMID 21200377.
«Synthesis and biodistribution of [11C]R107474, a new radiolabeled alpha2-adrenoceptor antagonist». Bioorg. Med. Chem. 14 (13): 4526–34. 2006. doi:10.1016/j.bmc.2006.02.029. PMID 16517171.
«Pharmacology of antidepressants». Mayo Clin. Proc. 76 (5): 511–27. 2001. doi:10.4065/76.5.511. PMID 11357798. https://archive.org/details/sim_mayo-clinic-proceedings_2001-05_76_5/page/511.
«Tricyclic antidepressant pharmacology and therapeutic drug interactions updated». Br. J. Pharmacol. 151 (6): 737–48. 2007. doi:10.1038/sj.bjp.0707253. PMID 17471183. PMC 2014120. https://archive.org/details/sim_british-journal-of-pharmacology_2007-07_151_6/page/737.
«Histamine H₁ receptor occupancy by the new-generation antidepressants fluvoxamine and mirtazapine: a positron emission tomography study in healthy volunteers». Psychopharmacology 230 (2): 227–34. 2013. doi:10.1007/s00213-013-3146-1. PMID 23728612.
«The atypical antidepressant mianserin exhibits agonist activity at κ-opioid receptors». British Journal of Pharmacology 167 (6): 1329–41. November 2012. doi:10.1111/j.1476-5381.2012.02078.x. PMID 22708686.
«Serotonin 5-HT_2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies». Thérapie 60 (5): 441–60. 2005. doi:10.2515/therapie:2005065. PMID 16433010.
«Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats: a pharmacological characterization». Psychopharmacology 203 (2): 329–41. April 2009. doi:10.1007/s00213-008-1259-8. PMID 18709360. https://archive.org/details/sim_psychopharmacology_2009-04_203_2/page/329.
«Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of α2-adrenergic and serotonin2C receptors: a comparison with citalopram». Eur. J. Neurosci. 12 (3): 1079–95. March 2000. doi:10.1046/j.1460-9568.2000.00982.x. PMID 10762339.
«Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram». The European Journal of Neuroscience 12 (3): 1079–95. March 2000. doi:10.1046/j.1460-9568.2000.00982.x. PMID 10762339.
«SB 206553, a putative 5-HT_2C inverse agonist, attenuates methamphetamine-seeking in rats». BMC Neuroscience 13 (1): 65. June 2012. doi:10.1186/1471-2202-13-65. PMID 22697313.
«Mirtazapine to reduce methamphetamine use: a randomized controlled trial». Archives of General Psychiatry 68 (11): 1168–75. November 2011. doi:10.1001/archgenpsychiatry.2011.124. PMID 22065532.
«Mirtazapine treatment after conditioning with methamphetamine alters subsequent expression of place preference». Drug and Alcohol Dependence 99 (1–3): 231–9. January 2009. doi:10.1016/j.drugalcdep.2008.08.005. PMID 18945553.
«Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions». Annals of Clinical Psychiatry 20 (3): 145–55. 2008. doi:10.1080/10401230802177656. PMID 18633741.
«Treatments for methamphetamine abuse: a literature review for the clinician». Journal of Pharmacy Practice 24 (6): 541–50. December 2011. doi:10.1177/0897190011426557. PMID 22095579.
«Pharmacotherapy of amphetamine-type stimulant dependence: an update». Drug and Alcohol Review 32 (5): 449–60. September 2013. doi:10.1111/dar.12048. PMID 23617468.
«Mirtazapine may be useful in treating nausea and insomnia of cancer chemotherapy». Supportive Care in Cancer 9 (6): 469–70. September 2001. doi:10.1007/s005200000215. PMID 11585276.
«Mirtazapine for treatment of nausea induced by selective serotonin reuptake inhibitors». Canadian Journal of Psychiatry 49 (10): 707. October 2004. doi:10.1177/070674370404901014. PMID 15560319. https://archive.org/details/sim_canadian-journal-of-psychiatry_2004-10_49_10/page/707.
«Mirtazapine overdose is unlikely to cause major toxicity». Clin Toxicol 52 (1): 20–4. 2014. doi:10.3109/15563650.2013.859264. PMID 24228948.
«[Serotonin syndrome after administration of mirtazapine in a critical care unit]» (στα Spanish). Rev Esp Anestesiol Reanim 56 (8): 515–6. 2009. doi:10.1016/s0034-9356(09)70444-x. PMID 19994622.
«Sertraline-induced serotonin syndrome followed by mirtazapine reaction». Prog. Neuropsychopharmacol. Biol. Psychiatry 34 (6): 1128–9. 2010. doi:10.1016/j.pnpbp.2010.04.015. PMID 20430060.
«A venlafaxine and mirtazapine-induced serotonin syndrome confirmed by de- and re-challenge». Int J Clin Pharm 34 (5): 686–8. 2012. doi:10.1007/s11096-012-9666-7. PMID 22752315.
«Mirtazapine: clinical advantages in the treatment of depression». Journal of Clinical Psychopharmacology 17 Suppl 1: 34S–39S. April 1997. doi:10.1097/00004714-199704001-00005. PMID 9090576.
Anttila, SA; Leinonen, EV (2001). «A review of the pharmacological and clinical profile of mirtazapine.». CNS Drug Reviews 7 (3): 249–64. doi:10.1111/j.1527-3458.2001.tb00198.x. PMID 11607047.
Kelder, J; Funke, C; De Boer, T; Delbressine, L; Leysen, D; Nickolson, V (April 1997). «A comparison of the physicochemical and biological properties of mirtazapine and mianserin.». The Journal of Pharmacy and Pharmacology 49 (4): 403–11. doi:10.1111/j.2042-7158.1997.tb06814.x. PMID 9232538.
Agnew, W; Korman, R (September 2014). «Pharmacological appetite stimulation: rational choices in the inappetent cat.». Journal of Feline Medicine and Surgery 16 (9): 749–56. doi:10.1177/1098612X14545273. PMID 25146662.

pubmedcentral.nih.gov

«A review of the pharmacological and clinical profile of mirtazapine». CNS Drug Rev 7 (3): 249–64. 2001. doi:10.1111/j.1527-3458.2001.tb00198.x. PMID 11607047.
«Mirtazapine versus other antidepressive agents for depression». The Cochrane Database of Systematic Reviews (12): CD006528. December 2011. doi:10.1002/14651858.CD006528.pub2. PMID 22161405.
«Suicidal antidepressant overdoses: a comparative analysis by antidepressant type». Journal of Medical Toxicology 4 (4): 238–50. December 2008. doi:10.1007/bf03161207. PMID 19031375.
«Tricyclic antidepressant pharmacology and therapeutic drug interactions updated». Br. J. Pharmacol. 151 (6): 737–48. 2007. doi:10.1038/sj.bjp.0707253. PMID 17471183. PMC 2014120. https://archive.org/details/sim_british-journal-of-pharmacology_2007-07_151_6/page/737.
«The atypical antidepressant mianserin exhibits agonist activity at κ-opioid receptors». British Journal of Pharmacology 167 (6): 1329–41. November 2012. doi:10.1111/j.1476-5381.2012.02078.x. PMID 22708686.
«SB 206553, a putative 5-HT_2C inverse agonist, attenuates methamphetamine-seeking in rats». BMC Neuroscience 13 (1): 65. June 2012. doi:10.1186/1471-2202-13-65. PMID 22697313.
«Mirtazapine to reduce methamphetamine use: a randomized controlled trial». Archives of General Psychiatry 68 (11): 1168–75. November 2011. doi:10.1001/archgenpsychiatry.2011.124. PMID 22065532.
«Pharmacotherapy of amphetamine-type stimulant dependence: an update». Drug and Alcohol Review 32 (5): 449–60. September 2013. doi:10.1111/dar.12048. PMID 23617468.
«Mirtazapine overdose is unlikely to cause major toxicity». Clin Toxicol 52 (1): 20–4. 2014. doi:10.3109/15563650.2013.859264. PMID 24228948.
Anttila, SA; Leinonen, EV (2001). «A review of the pharmacological and clinical profile of mirtazapine.». CNS Drug Reviews 7 (3): 249–64. doi:10.1111/j.1527-3458.2001.tb00198.x. PMID 11607047.

dailymed.nlm.nih.gov

«REMERON (mirtazapine) tablet, film coated [Organon Pharmaceuticals USA]». DailyMed. Organon Pharmaceuticals USA. Οκτωβρίου 2012. Ανακτήθηκε στις 24 Οκτωβρίου 2013.
«Mirataz- mirtazapine ointment». DailyMed. 8 Μαΐου 2020. Ανακτήθηκε στις 12 Ιουλίου 2020.

oxfordjournals.org

qjmed.oxfordjournals.org

«Itch: scratching more than the surface». QJM 96 (1): 7–26. January 2003. doi:10.1093/qjmed/hcg002. PMID 12509645. http://qjmed.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=12509645.

psychiatrictimes.com

«The Effects of Antidepressants on Sleep | Psychiatric Times». www.psychiatrictimes.com. Αρχειοθετήθηκε από το πρωτότυπο στις 10 Ιουνίου 2020. Ανακτήθηκε στις 11 Ιουλίου 2017.

rxlist.com

«Remeron (Mirtazapine) Drug Information». RxList. Ανακτήθηκε στις 28 Μαρτίου 2016.

semanticscholar.org

«Appetite stimulants in cystic fibrosis: a systematic review». Journal of Human Nutrition and Dietetics 20 (6): 526–37. December 2007. doi:10.1111/j.1365-277X.2007.00824.x. PMID 18001374. https://semanticscholar.org/paper/23bee19e5db3f46e66e00efa318ea014b1516dda.

pdfs.semanticscholar.org

«Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation» (PDF). Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 9 Ιανουαρίου 2018. Ανακτήθηκε στις 28 Σεπτεμβρίου 2020.

tga.gov.au

ebs.tga.gov.au

«Axit Mirtazapine PRODUCT INFORMATION». TGA eBusiness Services. alphapharm. 25 Οκτωβρίου 2011. Ανακτήθηκε στις 15 Οκτωβρίου 2013.

veterinarypartner.com

Roger Gfeller, D. V. M.; Michael Thomas, D. V. M.; Mayo, Isaac (2017-08-08). Mirtazapine (Remeron). http://www.veterinarypartner.com/Content.plx?P=A&A=2552.

vetinfo.com

«Remeron for Cats».

web.archive.org

«Mirtazapine 30 mg Tablets – Summary of Product Characteristics». electronic Medicines Compendium. Sandoz Limited. 20 Μαρτίου 2013. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 31 Ιουλίου 2017. Ανακτήθηκε στις 24 Οκτωβρίου 2013.
«The Effects of Antidepressants on Sleep | Psychiatric Times». www.psychiatrictimes.com. Αρχειοθετήθηκε από το πρωτότυπο στις 10 Ιουνίου 2020. Ανακτήθηκε στις 11 Ιουλίου 2017.
Stahl's Essential Psychopharmacology Online: Print and Online. Cambridge, UK: Cambridge University Press. 2008. ISBN 978-0-521-74609-0. Αρχειοθετήθηκε από το πρωτότυπο στις 19 Ιουνίου 2020. Ανακτήθηκε στις 28 Σεπτεμβρίου 2020.
«Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation» (PDF). Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 9 Ιανουαρίου 2018. Ανακτήθηκε στις 28 Σεπτεμβρίου 2020.
«Mirtazapine label – Australia». GuildLink, a wholly owned subsidiary company of the Pharmacy Guild of Australia. 27 Μαΐου 2016. Αρχειοθετήθηκε από το πρωτότυπο στις 21 Νοεμβρίου 2018. Ανακτήθηκε στις 28 Σεπτεμβρίου 2020.

worldcat.org

Wu, Chi-Shun; Tong, Show-Hwa; Ong, Cheung-Ter; Sung, Sheng-Feng (December 2015). «Serotonin Syndrome Induced by Combined Use of Mirtazapine and Olanzapine Complicated with Rhabdomyolysis, Acute Renal Failure, and Acute Pulmonary Edema-A Case Report». Acta Neurologica Taiwanica 24 (4): 117–121. ISSN 1028-768X. PMID 27333965.
Saguin, Emeric; Keou, S.; Ratnam, C.; Mennessier, C.; Delacour, H.; Lahutte, B. (May 2018). «Severe rhabdomyolysis induced by quetiapine and mirtazapine in a French military soldier». Journal of the Royal Army Medical Corps 164 (2): 127–129. doi:10.1136/jramc-2018-000939. ISSN 0035-8665. PMID 29632134.
Houlihan, David J. (March 2004). «Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine». The Annals of Pharmacotherapy 38 (3): 411–413. doi:10.1345/aph.1D344. ISSN 1060-0280. PMID 14970364. https://archive.org/details/sim_annals-of-pharmacotherapy_2004-03_38_3/page/411.